Cyclophosphamide
NDC 69097-517, Cyclophosphamide, capsule, from Cipla USA Inc..
- Product NDC
- 69097-517
- Status
- Listed
- Labeler
- Cipla USA Inc.
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA211608
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/69097-517 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CYCLOPHOSPHAMIDE50 mg/1
| Package NDC | NDC-11 | Package |
|---|---|---|
| 69097-517-07 | 69097051707 | 100 CAPSULE in 1 BOTTLE (69097-517-07) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/0e1cb955-99c8-4fe5-89d1-399c8e52174eMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=69097-517NADAC price for package 69097051707
GET /v1/drugs/nadac/69097051707
Use it
Look up 69097-517 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/69097-517 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 69097-517. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.